Walleye Trading’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-206,300
| Closed | -$1.88M | – | 4759 |
|
|
2025
Q2 | $1.88M | Buy |
+206,300
| New | +$1.52M | ﹤0.01% | 1761 |
|
|
2024
Q1 | – | Sell |
-14,800
| Closed | -$321K | – | 5268 |
|
|
2023
Q4 | $321K | Buy |
14,800
+13,800
| +1,380% | +$273K | ﹤0.01% | 3442 |
|
|
2023
Q3 | $20.6K | Sell |
1,000
-18,000
| -95% | -$520K | ﹤0.01% | 4390 |
|
|
2023
Q2 | $893K | Buy |
19,000
+17,600
| +1,257% | +$876K | ﹤0.01% | 2273 |
|
|
2023
Q1 | $58.7K | Sell |
1,400
-2,200
| -61% | -$94.6K | ﹤0.01% | 4025 |
|
|
2022
Q4 | $137K | Buy |
+3,600
| New | +$137K | ﹤0.01% | 3814 |
|
|
2021
Q4 | – | Sell |
-4,900
| Closed | -$217K | – | 5799 |
|
|
2021
Q3 | $217K | Buy |
4,900
+2,500
| +104% | +$115K | ﹤0.01% | 3771 |
|
|
2021
Q2 | $136K | Sell |
2,400
-12,200
| -84% | -$862K | ﹤0.01% | 4217 |
|
|
2021
Q1 | $1.09M | Buy |
14,600
+8,300
| +132% | +$680K | ﹤0.01% | 1841 |
|
|
2020
Q4 | $545K | Buy |
+6,300
| New | +$464K | ﹤0.01% | 2584 |
|
|
2020
Q3 | – | Sell |
-15,300
| Closed | -$636K | – | 4544 |
|
|
2020
Q2 | $636K | Buy |
15,300
+13,800
| +920% | +$501K | ﹤0.01% | 2063 |
|
|
2020
Q1 | $43K | Sell |
1,500
-1,900
| -56% | -$110K | ﹤0.01% | 3464 |
|
|
2019
Q4 | $245K | Sell |
3,400
-6,100
| -64% | -$750K | ﹤0.01% | 3004 |
|
|
2019
Q3 | $1.33M | Sell |
9,500
-12,200
| -56% | -$2.04M | 0.01% | 1381 |
|
|
2019
Q2 | $3.97M | Buy |
+21,700
| New | +$3.7M | 0.03% | 593 |
|
|
2018
Q4 | – | Sell |
-6,800
| Closed | -$961K | – | 5217 |
|
|
2018
Q3 | $961K | Buy |
+6,800
| New | +$1.05M | 0.01% | 2113 |
|
Other funds holding SAGE
IA
HNB
Walleye Trading's SAGE Position: Q3 2025 in Review
Walleye Trading sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 42,376 shares — an estimated $386K sold.
Walleye Trading first reported a position in SAGE in Q4 2015 and held it in 9 quarters. The position peaked at $674K in Q3 2019. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.
- Walleye Trading reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
- Walleye Trading sold 42,376 Sage Therapeutics shares in Q3 2025, an estimated $386K.
- Walleye Trading first reported a position in Sage Therapeutics in Q4 2015 and held it in 9 quarters.
- Walleye Trading's Sage Therapeutics position peaked at $674K in Q3 2019.
- 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.
Based on Walleye Trading's 13F filing for Q3 2025, filed 14 Nov 2025.